Horizon Therapeutics Sets Up

Horizon Therapeutics is trading tightly in short consolidation after a strong run. The IBD Stock Of The Day targets rare diseases. It boasts accelerating revenue growth thanks to a new drug. Profits have been spotty but analysts see big earnings growth for full-year 2020 and 2021.

View Article Origin Here